Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats
Background: Valproic acid (VPA) and topiramate (TPM), initially developed as antiepileptics, are approved for migraine prophylaxis in adults but not children. The differences in their antimigraine mechanism(s) by age remain unclear.Methods: A migraine model induced by intra-cisternal (i.c.) capsaici...
Main Authors: | Pokai Huang, Ping-Hung Kuo, Ming Tatt Lee, Lih-Chu Chiou, Pi-Chuan Fan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01095/full |
Similar Items
-
Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine
by: Pi-Chuan Fan, et al.
Published: (2019-01-01) -
Advances in topiramate as prophylactic treatment for migraine
by: Chuan Hu, et al.
Published: (2021-10-01) -
Serum Leptin Levels in Epileptic Patients Treated with Topiramate and Valproic Acid
by: İrem Fatma Uludağ, et al.
Published: (2011-03-01) -
Serum Leptin Levels in Epileptic Patients Treated with Topiramate and Valproic Acid
by: İrem Fatma Uludağ, et al.
Published: (2011-03-01) -
Prophylactic Treatment for Migraine in Children: Amitriptyline or Topiramate?
by: Gonca Bektaş
Published: (2017-06-01)